203 related articles for article (PubMed ID: 33145806)
1. PRDM1 decreases sensitivity of human NK cells to IL2-induced cell expansion by directly repressing CD25 (IL2RA).
Akman B; Hu X; Liu X; Hatipoğlu T; You H; Chan WC; Küçük C
J Leukoc Biol; 2021 May; 109(5):901-914. PubMed ID: 33145806
[TBL] [Abstract][Full Text] [Related]
2. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
[TBL] [Abstract][Full Text] [Related]
3. PRDM1 is a tumor suppressor gene in natural killer cell malignancies.
Küçük C; Iqbal J; Hu X; Gaulard P; De Leval L; Srivastava G; Au WY; McKeithan TW; Chan WC
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20119-24. PubMed ID: 22143801
[TBL] [Abstract][Full Text] [Related]
4. Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.
Gubbels JA; Gadbaw B; Buhtoiarov IN; Horibata S; Kapur AK; Patel D; Hank JA; Gillies SD; Sondel PM; Patankar MS; Connor J
Cancer Immunol Immunother; 2011 Dec; 60(12):1789-800. PubMed ID: 21792658
[TBL] [Abstract][Full Text] [Related]
5. Tethering IL2 to Its Receptor IL2Rβ Enhances Antitumor Activity and Expansion of Natural Killer NK92 Cells.
Jounaidi Y; Cotten JF; Miller KW; Forman SA
Cancer Res; 2017 Nov; 77(21):5938-5951. PubMed ID: 28916655
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells.
Rabinowich H; Herberman RB; Whiteside TL
Cell Immunol; 1993 Dec; 152(2):481-98. PubMed ID: 7903063
[TBL] [Abstract][Full Text] [Related]
7. Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3.
Takahara M; Kis LL; Nagy N; Liu A; Harabuchi Y; Klein G; Klein E
Int J Cancer; 2006 Dec; 119(12):2775-83. PubMed ID: 17013900
[TBL] [Abstract][Full Text] [Related]
8. Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways.
Dybkaer K; Iqbal J; Zhou G; Geng H; Xiao L; Schmitz A; d'Amore F; Chan WC
BMC Genomics; 2007 Jul; 8():230. PubMed ID: 17623099
[TBL] [Abstract][Full Text] [Related]
9. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A
Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220
[TBL] [Abstract][Full Text] [Related]
10. The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.
Liang L; Nong L; Zhang S; Zhao J; Ti H; Dong Y; Zhang B; Li T
J Exp Clin Cancer Res; 2014 Jan; 33(1):7. PubMed ID: 24438193
[TBL] [Abstract][Full Text] [Related]
11. CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells.
Pahl JHW; Koch J; Götz JJ; Arnold A; Reusch U; Gantke T; Rajkovic E; Treder M; Cerwenka A
Cancer Immunol Res; 2018 May; 6(5):517-527. PubMed ID: 29514797
[TBL] [Abstract][Full Text] [Related]
12. Site-specific pegylated IL2 mutein with biased IL2 receptor binding for cancer immunotherapy.
Tong B; Leong SG; Jian T; Niu G; Gai Y; Meng X; Lv H; Dong X; Ding X; Chen J
Int Immunopharmacol; 2024 Jul; 136():112359. PubMed ID: 38815348
[TBL] [Abstract][Full Text] [Related]
13. IL-2-dependent adaptive control of NK cell homeostasis.
Gasteiger G; Hemmers S; Bos PD; Sun JC; Rudensky AY
J Exp Med; 2013 Jun; 210(6):1179-87. PubMed ID: 23650439
[TBL] [Abstract][Full Text] [Related]
14. PRDM1/Blimp-1 controls effector cytokine production in human NK cells.
Smith MA; Maurin M; Cho HI; Becknell B; Freud AG; Yu J; Wei S; Djeu J; Celis E; Caligiuri MA; Wright KL
J Immunol; 2010 Nov; 185(10):6058-67. PubMed ID: 20944005
[TBL] [Abstract][Full Text] [Related]
15. Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1.
Dong G; Li Y; Lee L; Liu X; Shi Y; Liu X; Bouska A; Gong Q; Kong L; Wang J; Lou CH; McKeithan TW; Iqbal J; Chan WC
Haematologica; 2021 Sep; 106(9):2427-2438. PubMed ID: 32732362
[TBL] [Abstract][Full Text] [Related]
16. Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study.
Ingram W; Chan L; Guven H; Darling D; Kordasti S; Hardwick N; Barber L; Mufti GJ; Farzaneh F
Br J Haematol; 2009 Jun; 145(6):749-60. PubMed ID: 19388935
[TBL] [Abstract][Full Text] [Related]
17. Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1.
Baytak E; Gong Q; Akman B; Yuan H; Chan WC; Küçük C
Tumour Biol; 2017 May; 39(5):1010428317701648. PubMed ID: 28468592
[TBL] [Abstract][Full Text] [Related]
18. Pan-HDAC inhibitors augment IL2-induced proliferation of NK cells via the JAK2-STAT5B signaling pathway.
Zheng J; Lu Y; Xiao J; Duan Y; Zong S; Chen X; Hu T; Li L; Zhang Y
Int Immunopharmacol; 2023 Mar; 116():109753. PubMed ID: 36738675
[TBL] [Abstract][Full Text] [Related]
19. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.
Leong JW; Chase JM; Romee R; Schneider SE; Sullivan RP; Cooper MA; Fehniger TA
Biol Blood Marrow Transplant; 2014 Apr; 20(4):463-73. PubMed ID: 24434782
[TBL] [Abstract][Full Text] [Related]
20. Blimp-1/PRDM1 regulates the transcription of human CS1 (SLAMF7) gene in NK and B cells.
Kim JR; Mathew SO; Mathew PA
Immunobiology; 2016 Jan; 221(1):31-9. PubMed ID: 26310579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
